<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:georss="http://www.georss.org/georss" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:media="http://search.yahoo.com/mrss/"
	>

<channel>
	<title>CardioBrief</title>
	<atom:link href="http://cardiobrief.org/feed/" rel="self" type="application/rss+xml" />
	<link>http://cardiobrief.org</link>
	<description>One-stop source for cardiology news and links</description>
	<lastBuildDate>Fri, 27 Jan 2012 19:02:19 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.com/</generator>
<cloud domain='cardiobrief.org' port='80' path='/?rsscloud=notify' registerProcedure='' protocol='http-post' />
<image>
		<url>http://1.gravatar.com/blavatar/5706effc1b2c62d7b9c46c6c74eb5d86?s=96&#038;d=http%3A%2F%2Fs2.wp.com%2Fi%2Fbuttonw-com.png</url>
		<title>CardioBrief</title>
		<link>http://cardiobrief.org</link>
	</image>
	<atom:link rel="search" type="application/opensearchdescription+xml" href="http://cardiobrief.org/osd.xml" title="CardioBrief" />
	<atom:link rel='hub' href='http://cardiobrief.org/?pushpress=hub'/>
		<item>
		<title>ACC 2012 Roster of Late-Breaking Clinical Trials</title>
		<link>http://cardiobrief.org/2012/01/27/acc-2012-roster-of-late-breaking-clinical-trials/</link>
		<comments>http://cardiobrief.org/2012/01/27/acc-2012-roster-of-late-breaking-clinical-trials/#comments</comments>
		<pubDate>Fri, 27 Jan 2012 19:02:17 +0000</pubDate>
		<dc:creator>Larry Husten</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://cardiobrief.org/?p=10673</guid>
		<description><![CDATA[The American College of Cardiology has released the roster of late-breaking clinical trials that will be presented in March at the ACC Scientific Sessions: ACC.12 Opening Session and Late-Breaking Clinical Trials Saturday, March 24, 2012, 8:00 a.m. – 10:00 a.m. Effect of Transendocardial Autologous Bone Marrow Mononuclear Cell Delivery on Functional Capacity, Left Ventricular Function [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=cardiobrief.org&amp;blog=6145391&amp;post=10673&amp;subd=cardiobrief&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://cardiobrief.org/2012/01/27/acc-2012-roster-of-late-breaking-clinical-trials/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/5942cc097b5e0e6b0bc9d26e5c4fb3a1?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Larry</media:title>
		</media:content>
	</item>
		<item>
		<title>Lancet Editor Richard Horton Tweets Dark View of Contemporary Medicine</title>
		<link>http://cardiobrief.org/2012/01/27/lancet-editor-richard-horton-tweets-dark-view-of-contemporary-medicine/</link>
		<comments>http://cardiobrief.org/2012/01/27/lancet-editor-richard-horton-tweets-dark-view-of-contemporary-medicine/#comments</comments>
		<pubDate>Fri, 27 Jan 2012 17:46:28 +0000</pubDate>
		<dc:creator>Larry Husten</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[medical establishment]]></category>
		<category><![CDATA[richard horton]]></category>
		<category><![CDATA[tweets]]></category>
		<category><![CDATA[world health organization]]></category>

		<guid isPermaLink="false">http://cardiobrief.org/?p=10655</guid>
		<description><![CDATA[One brief message at a time, Lancet editor Richard Horton is tweeting his dark view of the contemporary medical establishment. If you have any interest at all in peeking behind the curtain to see what really goes on behind the scenes of top medical organizations then you need to follow Richard Horton&#8217;s Twitter feed. In sudden [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=cardiobrief.org&amp;blog=6145391&amp;post=10655&amp;subd=cardiobrief&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://cardiobrief.org/2012/01/27/lancet-editor-richard-horton-tweets-dark-view-of-contemporary-medicine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/5942cc097b5e0e6b0bc9d26e5c4fb3a1?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Larry</media:title>
		</media:content>

		<media:content url="http://cardiobrief.files.wordpress.com/2012/01/horton.jpg?w=274" medium="image">
			<media:title type="html">Horton</media:title>
		</media:content>
	</item>
		<item>
		<title>NHLBI Launches Two Large Cardiac Arrest Treatment Trials</title>
		<link>http://cardiobrief.org/2012/01/26/nhlbi-launches-two-large-cardiac-arrest-treatment-trials/</link>
		<comments>http://cardiobrief.org/2012/01/26/nhlbi-launches-two-large-cardiac-arrest-treatment-trials/#comments</comments>
		<pubDate>Thu, 26 Jan 2012 17:20:55 +0000</pubDate>
		<dc:creator>Larry Husten</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[ems teams]]></category>
		<category><![CDATA[professional cpr]]></category>
		<category><![CDATA[sudden cardiac arrest]]></category>

		<guid isPermaLink="false">http://cardiobrief.org/?p=10652</guid>
		<description><![CDATA[The NHLBI today announced the launch of two large clinical trials evaluating treatments for out-of-hospital cardiac arrest. The Continuous Chest Compressions (CCC) trial will randomize 23,600 people with out-of-hospital cardiac arrest to either standard CPR or continuous chest compressions, both delivered by paramedics or fire fighters. In recent years, studies published in the New England Journal of Medicine,  [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=cardiobrief.org&amp;blog=6145391&amp;post=10652&amp;subd=cardiobrief&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://cardiobrief.org/2012/01/26/nhlbi-launches-two-large-cardiac-arrest-treatment-trials/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/5942cc097b5e0e6b0bc9d26e5c4fb3a1?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Larry</media:title>
		</media:content>
	</item>
		<item>
		<title>Big Drop in Incidence and Fatality of MIs in England</title>
		<link>http://cardiobrief.org/2012/01/26/big-drop-in-incidence-and-fatality-of-mis-in-england/</link>
		<comments>http://cardiobrief.org/2012/01/26/big-drop-in-incidence-and-fatality-of-mis-in-england/#comments</comments>
		<pubDate>Thu, 26 Jan 2012 16:15:52 +0000</pubDate>
		<dc:creator>Larry Husten</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[acute myocardial infarction]]></category>
		<category><![CDATA[coronary heart disease]]></category>
		<category><![CDATA[myocardial infarction]]></category>

		<guid isPermaLink="false">http://cardiobrief.org/?p=10646</guid>
		<description><![CDATA[Since 2002 in England the incidence of acute MI has dropped by one-half and the case fatality rate by one-third, according to a new study published in BMJ. The overall decline in deaths from MI are about equally due to improvements in the prevention of MI and the treatment of MI. Kate Smolina and colleagues [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=cardiobrief.org&amp;blog=6145391&amp;post=10646&amp;subd=cardiobrief&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://cardiobrief.org/2012/01/26/big-drop-in-incidence-and-fatality-of-mis-in-england/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/5942cc097b5e0e6b0bc9d26e5c4fb3a1?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Larry</media:title>
		</media:content>
	</item>
		<item>
		<title>Huge Study Finds Risk Factors Do In Fact Predict Risk</title>
		<link>http://cardiobrief.org/2012/01/25/huge-study-finds-risk-factors-do-in-fact-predict-risk/</link>
		<comments>http://cardiobrief.org/2012/01/25/huge-study-finds-risk-factors-do-in-fact-predict-risk/#comments</comments>
		<pubDate>Wed, 25 Jan 2012 22:00:18 +0000</pubDate>
		<dc:creator>Larry Husten</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://cardiobrief.org/?p=10641</guid>
		<description><![CDATA[An enormous new meta-analysis confirms the important role that risk factors play over a lifetime in the development of cardiovascular disease. In a paper published in the New England Journal of Medicine, Jarett Berry and colleagues report on the new meta-analysis from the Cardiovascular Lifetime Risk Pooling Project, which contains data from 18 epidemiological studies including more than [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=cardiobrief.org&amp;blog=6145391&amp;post=10641&amp;subd=cardiobrief&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://cardiobrief.org/2012/01/25/huge-study-finds-risk-factors-do-in-fact-predict-risk/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/5942cc097b5e0e6b0bc9d26e5c4fb3a1?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Larry</media:title>
		</media:content>
	</item>
		<item>
		<title>FDA Rejects Proposed Chronic Kidney Disease Indication for Vytorin</title>
		<link>http://cardiobrief.org/2012/01/25/fda-rejects-proposed-chronic-kidney-disease-indication-for-vytorin/</link>
		<comments>http://cardiobrief.org/2012/01/25/fda-rejects-proposed-chronic-kidney-disease-indication-for-vytorin/#comments</comments>
		<pubDate>Wed, 25 Jan 2012 17:48:23 +0000</pubDate>
		<dc:creator>Larry Husten</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[chronic kidney disease]]></category>
		<category><![CDATA[dialysis patients]]></category>
		<category><![CDATA[ezetimibe and simvastatin]]></category>
		<category><![CDATA[fda decision]]></category>

		<guid isPermaLink="false">http://cardiobrief.org/?p=10635</guid>
		<description><![CDATA[The FDA rejected a new indication for Merck&#8217;s Vytorin and Zetia (ezetimibe plus simvastatin and ezetimibe alone) in chronic kidney disease patients. As a consolation prize, however, the agency approved a new label for Vytorin that will incorporate the results of SHARP (Study of Heart and Renal Protection), which found that Vytorin reduced the incidence of [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=cardiobrief.org&amp;blog=6145391&amp;post=10635&amp;subd=cardiobrief&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://cardiobrief.org/2012/01/25/fda-rejects-proposed-chronic-kidney-disease-indication-for-vytorin/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/5942cc097b5e0e6b0bc9d26e5c4fb3a1?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Larry</media:title>
		</media:content>
	</item>
		<item>
		<title>Whistleblower Lawsuit Filed Against 5 Cardiologists in Pennsylvania</title>
		<link>http://cardiobrief.org/2012/01/24/whistleblower-lawsuit-filed-against-5-cardiologists-in-pennsylvania/</link>
		<comments>http://cardiobrief.org/2012/01/24/whistleblower-lawsuit-filed-against-5-cardiologists-in-pennsylvania/#comments</comments>
		<pubDate>Tue, 24 Jan 2012 16:41:28 +0000</pubDate>
		<dc:creator>Larry Husten</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[pittsburgh medical center]]></category>
		<category><![CDATA[st joseph medical center]]></category>

		<guid isPermaLink="false">http://cardiobrief.org/?p=10630</guid>
		<description><![CDATA[The US government has joined a cardiologist in a whistleblower lawsuit against Hamot Medical Center  in western Pennsylvania  and a group of cardiologists with whom he once practiced, Ed Palattella reports in the Erie Times-News. Cardiologist Tullio Emanuele, who now practices in Kentucky, has accused five former colleagues, members of Medicor Associates Inc. and its affiliate, Flagship Cardiac, [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=cardiobrief.org&amp;blog=6145391&amp;post=10630&amp;subd=cardiobrief&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://cardiobrief.org/2012/01/24/whistleblower-lawsuit-filed-against-5-cardiologists-in-pennsylvania/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/5942cc097b5e0e6b0bc9d26e5c4fb3a1?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Larry</media:title>
		</media:content>
	</item>
		<item>
		<title>Black Tea Found To Lower Blood Pressure</title>
		<link>http://cardiobrief.org/2012/01/24/black-tea-found-to-lower-blood-pressure/</link>
		<comments>http://cardiobrief.org/2012/01/24/black-tea-found-to-lower-blood-pressure/#comments</comments>
		<pubDate>Tue, 24 Jan 2012 14:36:29 +0000</pubDate>
		<dc:creator>Larry Husten</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://cardiobrief.org/?p=10618</guid>
		<description><![CDATA[A new study published in Archives of Internal Medicine provides the best evidence yet that drinking black tea can lower blood pressure. Jonathan M. Hodgson and colleagues randomized 95 regular tea drinkers to either 3 cups per day of either black tea (containing 429 mg of polyphenols and 96 mg of caffeine) or placebo. At 3 and 6 [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=cardiobrief.org&amp;blog=6145391&amp;post=10618&amp;subd=cardiobrief&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://cardiobrief.org/2012/01/24/black-tea-found-to-lower-blood-pressure/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/5942cc097b5e0e6b0bc9d26e5c4fb3a1?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Larry</media:title>
		</media:content>
	</item>
		<item>
		<title>St Jude Medical Statement on the Riata ICD Lead Summit</title>
		<link>http://cardiobrief.org/2012/01/23/st-jude-medical-statement-on-the-riata-icd-lead-summit/</link>
		<comments>http://cardiobrief.org/2012/01/23/st-jude-medical-statement-on-the-riata-icd-lead-summit/#comments</comments>
		<pubDate>Mon, 23 Jan 2012 19:01:22 +0000</pubDate>
		<dc:creator>Larry Husten</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[st jude medical]]></category>

		<guid isPermaLink="false">http://cardiobrief.org/?p=10619</guid>
		<description><![CDATA[In response to the guest post summarizing the Riata ICD Lead Summit, St. Jude Medical sent the following statement to CardioBrief: We recognize that the phenomenon of externalized conductors presents a complex patient management scenario for physicians who may be able to visualize an anomaly, but it is important to remember that most leads with [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=cardiobrief.org&amp;blog=6145391&amp;post=10619&amp;subd=cardiobrief&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://cardiobrief.org/2012/01/23/st-jude-medical-statement-on-the-riata-icd-lead-summit/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/5942cc097b5e0e6b0bc9d26e5c4fb3a1?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Larry</media:title>
		</media:content>
	</item>
		<item>
		<title>Rita Redberg and Roger Blumenthal Clash Over Statins for Primary Prevention in the Wall Street Journal</title>
		<link>http://cardiobrief.org/2012/01/23/rita-redberg-and-roger-blumenthal-clash-over-statins-for-primary-prevention-in-the-wall-street-journal/</link>
		<comments>http://cardiobrief.org/2012/01/23/rita-redberg-and-roger-blumenthal-clash-over-statins-for-primary-prevention-in-the-wall-street-journal/#comments</comments>
		<pubDate>Mon, 23 Jan 2012 18:06:49 +0000</pubDate>
		<dc:creator>Larry Husten</dc:creator>
				<category><![CDATA[Uncategorized]]></category>
		<category><![CDATA[mortality benefit]]></category>
		<category><![CDATA[primary prevention]]></category>

		<guid isPermaLink="false">http://cardiobrief.org/?p=10615</guid>
		<description><![CDATA[The debate over whether statins should be used for primary prevention moved to the Wall Street Journal with opposing perspectives from cardiologists Roger Blumenthal and Rita Redberg. Blumenthal argues that &#8220;there is a mountain of high-quality scientific evidence&#8221; to support the use of statins in people without known heart disease but &#8220;demonstrated to be at high [...]<img alt="" border="0" src="http://stats.wordpress.com/b.gif?host=cardiobrief.org&amp;blog=6145391&amp;post=10615&amp;subd=cardiobrief&amp;ref=&amp;feed=1" width="1" height="1" />]]></description>
		<wfw:commentRss>http://cardiobrief.org/2012/01/23/rita-redberg-and-roger-blumenthal-clash-over-statins-for-primary-prevention-in-the-wall-street-journal/feed/</wfw:commentRss>
		<slash:comments>6</slash:comments>
	
		<media:content url="http://1.gravatar.com/avatar/5942cc097b5e0e6b0bc9d26e5c4fb3a1?s=96&#38;d=identicon&#38;r=G" medium="image">
			<media:title type="html">Larry</media:title>
		</media:content>
	</item>
	</channel>
</rss>
